Anthropic's IPO Is the Real Safety Signal
Anthropic is heading toward a $100bn revenue run rate and an IPO, even as its CEO warns the industry to slow down.
Mainline Desk

Anthropic is on track to hit $100 billion in annualised revenue this year and is preparing for a public listing, even as chief executive Dario Amodei continues to argue that development of some advanced models should slow down, the New York Times reports. The company also shipped Opus 5.5 this week, pitched partly on the strength of its internal safety testing.
The contradiction here isn’t hypocrisy, it’s structure. Amodei’s safety warnings have always been about specific capability thresholds — models that could meaningfully assist in bioweapons design, say, or that show signs of deceptive planning. They were never a pledge to slow revenue growth, and revenue growth is what an IPO prospectus is built to demonstrate. A company can genuinely believe frontier capability needs guardrails while still racing to scale the parts of the business that don’t trip those guardrails. Enterprise contracts, API calls, coding assistants — none of that requires the kind of model Amodei is nervous about. It just requires a model that’s reliable and cheap enough to run at volume.
What the S-1 will actually have to say
The harder problem is what happens when “we’re being careful” has to survive contact with a prospectus. Public markets don’t reward hedged language. Anthropic’s pitch to investors will need to describe a growth trajectory that looks unbounded, filed by the same executive team that has spent two years telling Congress and the press that this technology needs external limits. Those two documents — the S-1 and the safety testimony — will sit next to each other indefinitely, and analysts will be paid to find the gap between them. Every future capability warning from Amodei will now be read against a share price. That’s not a hypothetical risk; it’s the mechanism by which public safety rhetoric from AI labs quietly softens once shareholders are in the room. It happened, in slower motion, at OpenAI once it needed capital at scale.
The pricing war is the tell
Worth reading alongside this is Ars Technica’s observation that Anthropic and OpenAI’s latest models are converging on the same pitch: a little more capability for a lot less money. That’s not what a market preparing to slow down looks like. It’s what a market preparing to compete on unit economics looks like — the signature move of an industry approaching commodity pricing, which is usually the point at which the biggest players start optimising for scale and margin rather than restraint. An IPO is simply the financing instrument that lets Anthropic do that from a position of strength rather than desperation. Amodei’s caution may be sincere. The prospectus will still be written by the growth team.
Reported at the New York Times; analysis ours.
Newsletter
A daily read on tech, markets, and what they signal
Get Mainline in your inbox. No spam, and one click to leave.
Every weekday morning · Unsubscribe any time. We never sell or rent your address; read the privacy policy.